Nucleus Capital
Jenny Saft is a Co-Founder of Apryl, a fertility benefits platform aimed at assisting companies in attracting and retaining talent while promoting diversity and inclusion, since October 2019. In addition, Jenny serves as an investor at Nucleus Capital, which focuses on funding purpose-driven entrepreneurs addressing systemic issues in human and planetary health. As an angel investor in the Atomico Angel Programme, Jenny has invested in early-stage startups in Europe. Previous roles include VP of Business Development DACH and Strategic Partnership Development Manager at Adyen, as well as positions in business operations and strategy at Fyber. Jenny's career began at Deutsche Telekom AG, where responsibilities included managing retail strategy and supporting the CTIO Board Member. Educational background includes an MBA with Distinction from Hult International Business School and a BA in Business Administration from FHDW Bielefeld, University of Applied Sciences.
This person is not in any teams
Nucleus Capital
Nucleus Capital is a new venture capital firm supporting purpose-driven founders. We profoundly believe that entrepreneurial innovation is necessary to tackle global threats to human and planetary health. We partner with entrepreneurs at the nucleus of their journey, investing at the Pre/Seed stage and are focussed on Synthetic &Computational Biology, Food- and Climate Technology.